Inhibrx Biosciences, Inc. INBX Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$33.44M+22.8% | -$32.83M— | -$35.26M+19.6% | -$28.65M-102% | -$43.31M+45.0% | ||
| $537K-20.4% | $564K-18.1% | $582K-23.4% | $662K+39.4% | $675K+87.5% | ||
| $2.65M+8.3% | $2.74M-8.0% | $3.18M+7.1% | $2.77M-94.0% | $2.45M-61.7% | ||
| -$38.03M-5.9% | -$30.12M+31.1% | -$33.82M-11.7% | -$29.95M+47.8% | -$35.9M+43.1% | ||
| $0-100% | —— | $10K-96.0% | —— | $21K-98.1% | ||
| $0+100% | —— | -$7K+97.2% | —— | -$21K+98.1% | ||
| $75.46M-24.4% | $1.25M— | $352K— | $0-100% | $99.84M+158% | ||
| $37.44M-41.4% | -$28.87M+34.0% | —— | —— | $63.92M+351% | ||
| -$38.03M-5.9% | -$30.12M+31.1% | -$33.83M-10.8% | -$29.95M+48.9% | -$35.92M+44.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Inhibrx Biosciences, Inc. generate?
- Inhibrx Biosciences, Inc. (INBX) generated -$131.9M in operating cash flow over the trailing twelve months.
- What is Inhibrx Biosciences, Inc.'s free cash flow?
- After $47.0K of capital expenditures, Inhibrx Biosciences, Inc.'s free cash flow was -$131.9M over the trailing twelve months, up 21.8% year over year.
- Where does Inhibrx Biosciences, Inc.'s cash flow data come from?
- Every line is extracted from Inhibrx Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.